0001225208-13-013595.txt : 20130531
0001225208-13-013595.hdr.sgml : 20130531
20130531181400
ACCESSION NUMBER: 0001225208-13-013595
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130530
FILED AS OF DATE: 20130531
DATE AS OF CHANGE: 20130531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIGAL ELLIOT
CENTRAL INDEX KEY: 0001202294
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 13886190
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
4
1
doc4.xml
X0306
4
2013-05-30
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001202294
SIGAL ELLIOT
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
1
EVP, CSO & President R&D
Common Stock, $0.10 par value
2013-05-30
4
M
0
120625.0000
27.0100
A
226514.0000
D
Common Stock, $0.10 par value
2013-05-30
4
M
0
50000.0000
24.7400
A
276514.0000
D
Common Stock, $0.10 par value
2013-05-30
4
S
0
143521.0000
47.2300
D
132993.0000
D
Common Stock, $0.10 par value
1628.0600
I
By BMY Savings & Investment Program
Common Stock, $0.10 par value
18180.0000
I
By C. Elliott Sigal 2012 Irrevocable Trust
Common Stock, $0.10 par value
18180.0000
I
By Ruth L. Sigal Irrevocable Trust
Common Stock, $0.10 par value
9091.0000
I
By Sigal Family Investments, LLC
Executive Option (right to buy)
27.0100
2013-05-30
4
M
0
120625.0000
0.0000
D
2017-03-05
Common Stock, $0.10 par value
120625.0000
123875.0000
D
Executive Option (right to buy)
24.7400
2013-05-30
4
M
0
50000.0000
0.0000
D
2016-11-30
Common Stock, $0.10 par value
50000.0000
0.0000
D
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $47.15 to $47.43, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Based on a plan statement as of the end of the most recent fiscal quarter.
Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 6, 2007.
One-third of the stock option award vested on each of the third, fourth and fifth anniversaries of the grant date, which was December 1, 2006.
/s/ Robert J. Wollin, attorney-in-fact for Elliott Sigal, M.D., Ph.D
2013-05-31